The FDA has again slammed a Japanese drug company in a warning letter, this time for not doing enough to prevent contamination during aseptic filling.

Sun Pharma says it could be a few more quarters before it resolves FDA concerns over its key plant in Halol, a situation that continues to be a drag on its…

India’s Aurobindo has acquired four biosimilar products from a Swiss company and says it is building a manufacturing plant to support the production of those…

In a meeting with a host of Big Pharma execs last week, President Trump urged them to build plants and manufacture drugs in the U.S. Now a new U.S. plant has…

China’s Kangmei Pharma, a company focused on oral traditional Chinese medicine, intends to pour $146 million into a healthcare industry fund.

Dr. Reddy’s Laboratories said regulatory problems with its substitute supplier may keep it from getting to market this quarter with a generic of blockbuster…

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

India’s Strides Shasun has decided to radically remake itself, focusing on a consumer formulations business it will call Strides Pharma and spinning or selling…

In this week's FiercePharmaAsia wrap-up, FibroGen and AZ prepare for an NDA in China, Astellas buys eardrum med's rights, and Takeda pledges 10%…

Pharma Asia